Please login to the form below

Not currently logged in
Email:
Password:

Amgen poaches J&J’s Ray Jordan for corporate affairs post

He joins on October, 1 with a strategic communications remit

Amgen has appointed Ray Jordan to fill the newly created position of senior vice president of corporate affairs.

He will join the US biotech on October, 1 from Johnson & Johnson, where he has served as communications leader with responsibility for corporate comms and public affairs since 2003.

Prior to joining J&J, Jordan was vice president of communications and information for Pfizer, where he held a range of positions over the course of 17 years.

He has also served as chair of PhRMA's public affairs section and, earlier in his career, as a reporter for a regional daily newspaper as well as holding positions with Bristol-Myers and business information company Dun & Bradstreet.

In his new role Jordan will be responsible for strategic communications across Amgen, including internal and external communications, issues management and philanthropy, and report directly to Robert Bradway, Amgen's president and CEO.

Bradway said: "We are very pleased to have Ray join Amgen. He is a strategic thinker and communicator with skills honed at two respected global health care companies.

“Ray's background in both business management and communication will serve Amgen well as we execute on our strategy to deliver results for both patients and shareholders."

12th September 2012

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashley Communications

Ashley Communications is a bespoke, independent medical communications consultancy consistently providing a unique director-delivered client service tailored to individual client...

Latest intelligence

How did pharma use Twitter at #ASCO16?
Each year, ASCO’s Annual Meeting brings together 30,000 oncology professionals from around the world, here we explore the #ASCO16 hashtag and how pharma utilised the channel during this year's event....
WHITE PAPER: How to engage with HCPs more effectively
Shrinking budgets and limitations on the time HCPs can spend with sales reps is making traditional engagement methods more and more ineffective. So, in order to reach the unreachable, pharma...
Evolve or die
How brand teams can bring more value to their customers...

Infographics